Subjective effects of additional doses of buprenorphine in patients on buprenorphine maintenance

Addictive Behaviors

Volumn 32, Issue 2, 2007, Pages 320-331

  Singhal, A ^a   Tripathi, B M ^a   Pal, H R ^a   Jena, R ^a   Jain, R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Abuse liability; Buprenorphine maintenance; Subjective effects

Indexed keywords

AMPHETAMINE DERIVATIVE; BARBITURIC ACID DERIVATIVE; BUPRENORPHINE; CANNABINOID; CHLORDIAZEPOXIDE; CODEINE; DEXTROPROPOXYPHENE; DIAZEPAM; HYDROMORPHONE; MORPHINE; NITRAZEPAM; PENTAZOCINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; DRUG DOSE INCREASE; DRUG EFFECT; DYSPHORIA; EUPHORIA; HOSPITAL PATIENT; HUMAN; MAINTENANCE THERAPY; MALE; OPIATE ADDICTION; PATIENT ATTITUDE; SIDE EFFECT; SOMNOLENCE;

ADULT; BUPRENORPHINE; CHI-SQUARE DISTRIBUTION; DRUG ADMINISTRATION SCHEDULE; HEROIN DEPENDENCE; HUMANS; MALE; MIDDLE AGED; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; QUESTIONNAIRES;

EID: 33845481285     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2006.05.003     Document Type: Article

References (28)

1. Bedi N.S., Ray R., Jain R., and Dhar N.K. Abuse liability of buprenorphine - A study among experienced drug users. Indian Journal of Physiology and Pharmacology 42 (1998) 95-100
2. Blom Y., Bondesson U., and Gunne L.S. Effects of burenorphine in heroin addicts. Drug and Alcohol Dependence 20 (1987) 1-7
3. Folstein M.F., and Luria R. Reliability, validity and clinical application of the visual analog scale. Psychological Medicine 3 (1973) 479-486
4. Foltin R.W., and Fischman M.W. Effects of buprenorphine on the administration of cocaine by humans. Behavioural Pharmacology 5 (1994) 79-89
5. Foltin R.W., and Fischman M.W. Interaction of buprenorphine with cocaine - morphine combinations. Experimental and Clinical Psychopharmacology 3 (1995) 261-269
6. Fraser H.F., Vanforn G.D., Martin W.R., Walbach A.B., and Isbell H. Methods for evaluating addiction liability. Journal of Pharmacology and Experimental Therapeutics 133 (1961) 371-387
7. Haertzen C.A. Development of scales based on patterns of drug effects, using the Addiction Research Center Inventory (ARCI). Psychological Reports 18 (1966) 163-194
8. Haertzen C.A. An overview of Addiction Research Center Inventory scales (ARCI): An appendix and manual of scales. DHEW Publication Vol. ADM 74-92 (1974), National Institute on Drug Abuse, Rockville, MD
9. Haertzen C.A., and Hickey J.E. Addiction Research Centre Inventory (ARCI): Measurement of euphoria and other drug effects. In: Bozarth M.A. (Ed). Methods of assessing the reinforcing properties of abused drugs (1987), Springer Verlag, New York 489-524
10. Jain R. Detection of drugs of abuse in body fluids - A manual for laboratory personnel (1998), Drug Dependence Treatment Centre, AIIMS, New Delhi
11. Jasinski D.R., Fudala P.J., and Johnson R.E. Sublingual versus subcutaneous buprenorphine in opiate abusers. Clinical Pharmacology and Therapeutics 45 (1989) 513-519
12. Jasinski D.R., Pevnick J.S., and Griffith J.D. Human pharmacology and abuse potential of the analgesic buprenorphine. Archives of General Psychiatry 35 (1978) 501-516
13. Jones H.E., Bigelow G.E., and Preston K.L. Assessment of opioid partial agonist activity with a 3 choice hydromorphone dose discrimination procedure. Journal of Pharmacology and Experimental Therapeutics 289 (1999) 1350-1361
14. Macdonald F.C., Gough K.J., Nicoll R.A., and Dow R.J. Psychomotor effects of ketorolac in comparison with buprenorphine and diclofenac. British Journal of Clinical Pharmacology 27 (1989) 453-459
15. Manner T., Kanto J., and Solomen M. Simple devices in differentiating the effects of buprenorphine and fentanyl in healthy volunteers. European Journal of Clinical Pharmacology 31 (1987) 673-676
16. Mohan D., and Ray R. Community based treatment for heroin dependence in an urban slum of Delhi (India) - Report submitted to WHO (1997), SEARO, New Delhi, India
17. Pickworth W.B., Johnson R.E., Holicky B.A., and Coney E.J. Subjective and physiologic effect of i/v buprenorphine in human. Clinical Pharmacology and Therapeutics 53 (1993) 570-576
18. Preston K.L., and Bigelow G.E. Drug discrimination assessment of agonist-antagonist opioids in humans. A three-choice saline-hydromorphone-butorphenol procedure. Journal of Pharmacology and Experimental Therapeutics 271 (1994) 48-60
19. Preston K.L., and Bigelow G.E. Effects of agonist and antagonist opioids in humans trained in hydromorphone - not hydromorphone discrimination. Journal of Pharmacology and Experimental Therapeutics 295 (2000) 114-124
20. Preston K.L., Bigelow G.E., Bickel W.K., and Liebson I.A. Drug discrimination in human post addicts: Agonist-antagonist opioids. Journal of Pharmacology and Experimental Therapeutics 250 (1989) 184-196
21. Preston K.L., Liebson I.A., and Bigelow G.E. Discrimination of agonist-antagonist opioids in humans trained on a two-choice saline hydromorphone discrimination. Journal of Pharmacology and Experimental Therapeutics 261 (1992) 62-71
22. Saarialho-Kere U., Mattile M.J., Paloheimo M., and Seppala S. Psychomotor, respiratory and neuroendocrinological effect of buprenorphine and amytryptiline in healthy volunteers. European Journal of Clinical Pharmacology 33 (1987) 139-146
23. Strain E.C., Stoller K., Walsh S.L., and Bigelow G.E. Effects of buprenorphine versus buprenorphine naloxone tablets in non-dependent opioid abusers. Psychopharmacology 148 (2000) 374-383
24. Strain E.C., Walsh S.L., Preston K.L., Liebson I.A., and Bigelow G.E. The effects of buprenorphine in buprenorphine maintained volunteers. Psychopharmacology 129 (1997) 329-338
25. Walsh S.L., Preston K.L., Bigelow G.E., and Stitzer M.L. Acute administration of buprenorphine in human: Partial agonist and blockade effects. Journal of Pharmacology and Experimental Therapeutics 274 (1995) 361-372
26. Walsh S.L., Preston K.L., Stitzer M.L., Cone E.J., and Bigelow G.E. Clinical pharmacology of buprenorphine: Ceiling effects at high doses. Clinical Pharmacology and Therapeutics 55 (1994) 569-580
27. Weinhold L.L., Preston K.L., Farre M., Liebson I.A., and Bigelow G.E. Buprenorphine alone and in combination with naloxone in nondependent humans. Drug and Alcohol Dependence 30 (1992) 263-274
28. Zacny J.P., Conley K., and Marks S. Comparing the subjective psychomotor and physiological effects of intravenous nalbuphine and morphine in healthy volunteers. Journal of Pharmacology and Experimental Therapeutics 280 (1997) 1159-1169